The spirometer market is expected to grow from US$ 893.71 million in 2021  to US$ 1,907.36 million by 2028. It is estimated to grow at a CAGR of 11.5% during 2022–2028.

A spirometer is a diagnostic device that measures the circulation of air into and out of the lungs. Obstructive and restrictive aberrant ventilation patterns are identified using the spirogram. A spirometer is the primary preferred equipment used for basic pulmonary function tests (PFTs). The tests may rule out lung illnesses, including asthma, bronchitis, and emphysema. Furthermore, a spirometer is frequently used to determine the cause of breath shortness, analyze the influence of pollutants on lung function, the effect of medicine, and evaluate the treatment progress of the disease.

The spirometer market is segmented based on type, technology, application, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends and market dynamics, and the competitive analysis of the globally leading market players.   

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Spirometer Market: Strategic Insights

Spirometer Market

• 
  CAGR (2021 - 2028)

  11.5%
• Market Size 2021
  US$ 893.71 Million
• Market Size 2028
  US$ 1,907.36 Million

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Jones Medical Instrument Company
• Benson Medical Instruments Co.
• NUVOAIR U.S, INC. (NUVOAIR AB)
• Teleflex Incorporated
• VYAIRE MEDICAL, INC.
• COSMED Srl
• Depisteo LLC.
• Henry Schein, Inc.
• Baxter International Inc.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Handheld Spirometers
• Table-Top Spirometers
• Desktop Spirometers

Technology

• Volume
• Flow
• Peak Flow

Application

• Asthma
• Chronic Obstructive Pulmonary Disease
• Cystic Fibrosis
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights and Developments
Rising Prevalence of Respiratory Diseases Drives Spirometer Market

The higher prevalence of respiratory disorders is related to the decrease in the size of the upper airway lumen in the aging population. Lung diseases are among the most common medical conditions across the world. Further, millions of people are suffering from various types of respiratory diseases. Moreover, smoking, genetic factors, and infections are among the common factors responsible for respiratory diseases. Medical conditions, including asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis, and lung cancer, are significant public health burdens. Patients suffering from respiratory disorders commonly experience difficulty in breathing. Further, early detection and diagnosis can help in treating patients suffering from respiratory diseases. To treat these patients, spirometry is a crucial technology that assists in indulging in the severity of the infection and avoids misdiagnosis. Thus, the increasing incidence of respiratory diseases drives the growth of the market.

A few developments by companies are listed below:

• In January 2022, ICU Medical announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes a syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of ~US$2.5 billion.
• In December 2021, Baxter announced the acquisition of Hill-rom. This combination unlocked the next phase of the company's transformation for greater impact on patients, employees, clinicians, and shareholders worldwide. Hill-Rom is among the leading manufacturers of spirometry products.
• In February 2020, COSMED acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for hemodynamic (cardiac output), ventilation heterogeneity (lung clearance index), and metabolic measurements (VO2Max).
• In August 2019, Hill-Rom entered a definitive agreement to acquire Breathe Technologies, Inc., developer and manufacturer of a patented wearable, noninvasive ventilation technology that supports improved patient mobility, for a cash consideration of US$130 million.

Such developments by market players are driving the spirometer market.   

Type Insights

Based on type, the spirometer market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. The table-top spirometers segment holds the largest market share in 2022. However, the handheld spirometers segment is anticipated to register the highest CAGR during the forecast period due to the emergence of small, lightweight, and easily portable handheld spirometers becoming universal in the industry.

Technology Insights

Based on Technology, the spirometer market is segmented into volume, flow, and peak flow. In 2022, the flow segment holds the largest market share. However, the peak flow segment is expected to register the highest CAGR from 2022 to 2028, due to its working pattern as patients blow into a mouthpiece at one end of the device, and the peak flow meter measures the force of the air flowing out of the lungs in liters per minute.

Application Insights

Based on application, the spirometer market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. In 2022, the chronic obstructive pulmonary disease segment holds the largest share of the market. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028, owing to the growing prevalence of COPD and the adoption of easy diagnosis of COPD offered by spirometry.

Organic developments, including product launches, are highly adopted strategies by the global spirometer market players. A few of the recent key market developments are listed below:

• In November 2021, COSMED launched the 2nd generation of OMNIA software, the most comprehensive data management platform for metabolic, lung function, and body composition assessment.
• In April 2021, the US FDA cleared NuvoAir's Air Next connected spirometer device. According to the FDA’s premarket notification database, the Stockholm, Sweden-based company submitted its application in November 2018.

Spirometer – Market Segmentation

The global spirometer market is segmented based on type, technology, application, and geography. Based on type, the market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. Based on technology, the market is segmented into volume, flow, and peak flow. Based on application, the spirometer market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. By geography, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.  

Spirometer Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Company Profiles

• Jones Medical Instrument Company        
• Benson Medical Instruments Co.    
• Nuvoair AB           
• Teleflex Incorporated        
• Vyaire Medical, Inc.           
• COSMED srl           
• Depisteo LLC          
• Henry Schein, Inc    
• Baxter International Inc.    
• ICU Medical Inc.